Laboratorios Farmaceuticos Rovi Stock Fundamentals
| ROVI Stock | EUR 63.05 0.05 0.08% |
Laboratorios Farmaceuticos ROVI fundamentals help investors to digest information that contributes to Laboratorios Farmaceuticos' financial success or failures. It also enables traders to predict the movement of Laboratorios Stock. The fundamental analysis module provides a way to measure Laboratorios Farmaceuticos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratorios Farmaceuticos stock.
Laboratorios |
Laboratorios Farmaceuticos ROVI Company Return On Equity Analysis
Laboratorios Farmaceuticos' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Laboratorios Farmaceuticos Return On Equity | 0.39 |
Most of Laboratorios Farmaceuticos' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratorios Farmaceuticos ROVI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Laboratorios Farmaceuticos ROVI has a Return On Equity of 0.3919. This is 101.63% lower than that of the Pharmaceuticals sector and 101.07% lower than that of the Health Care industry. The return on equity for all Spain stocks is notably lower than that of the firm.
Laboratorios Farmaceuticos Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Farmaceuticos's current stock value. Our valuation model uses many indicators to compare Laboratorios Farmaceuticos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Farmaceuticos competition to find correlations between indicators driving Laboratorios Farmaceuticos's intrinsic value. More Info.Laboratorios Farmaceuticos ROVI is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratorios Farmaceuticos ROVI is roughly 2.13 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Laboratorios Farmaceuticos by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Laboratorios Farmaceuticos' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Laboratorios Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratorios Farmaceuticos' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratorios Farmaceuticos could also be used in its relative valuation, which is a method of valuing Laboratorios Farmaceuticos by comparing valuation metrics of similar companies.Laboratorios Farmaceuticos is currently under evaluation in return on equity category among its peers.
Laboratorios Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Shares Owned By Insiders | 60.25 % | |||
| Shares Owned By Institutions | 17.88 % | |||
| Price To Earning | 43.87 X | |||
| Price To Book | 4.42 X | |||
| Price To Sales | 2.54 X | |||
| Revenue | 648.68 M | |||
| Gross Profit | 379.83 M | |||
| EBITDA | 204.66 M | |||
| Net Income | 182.63 M | |||
| Cash And Equivalents | 126.82 M | |||
| Cash Per Share | 2.26 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.62 X | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.33 X | |||
| Price To Earnings To Growth | 3.17 X | |||
| Target Price | 68.09 | |||
| Number Of Employees | 1.75 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 2.1 B | |||
| Total Asset | 732.68 M | |||
| Z Score | 23.4 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 0.87 % | |||
| Net Asset | 732.68 M |
About Laboratorios Farmaceuticos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratorios Farmaceuticos ROVI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratorios Farmaceuticos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratorios Farmaceuticos ROVI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. LABORATORIOS FARMACEUTICOS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1499 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Laboratorios Stock
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.